Esketamine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Esketamine and local guidelines before prescribing.

NMDA antagonist

Mechanism

NMDA receptor antagonist nasal spray.

Uses

Treatment-resistant depression (specialist).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Dissociation, hypertension, nausea, dizziness.

Interactions

CNS depressants.

Contraindications and cautions

Uncontrolled hypertension, aneurysm

Monitoring

BP

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Caution in hepatic impairment

Overdose and reversal

Supportive

Special advice

Supervised administration with 2-hour observation.

More from the textbook: uses, cautions and other points
Where it is discussed in the book